FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Flemming Vassbotn

Research Profile

Chemicals & Drugs

Physiology

Anatomy

Living Beings

Co-author Network

Publications

TOP 3
Jeanette Hess-Erga; Per Møller; Flemming S Vassbotn
Long-term hearing result using Kurz titanium ossicular implants.
Tore Helgaland; Bart Engelen; Carla Olsnes; Hans Jørgen Aarstad; Flemming S Vassbotn
In vitro cholesteatoma growth and secretion of cytokines.
Flemming S Vassbotn; Per Møller; Juha Silvola
Short-term results using Kurz titanium ossicular implants.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Flemming Vassbotn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jeanette Hess-Erga; Per Møller; Flemming S Vassbotn
Long-term hearing result using Kurz titanium ossicular implants.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2013;270(6):1817-21.
2010: Tore Helgaland; Bart Engelen; Carla Olsnes; Hans Jørgen Aarstad; Flemming S Vassbotn
In vitro cholesteatoma growth and secretion of cytokines.
Acta oto-laryngologica 2010;130(7):815-9.
2007: Flemming S Vassbotn; Per Møller; Juha Silvola
Short-term results using Kurz titanium ossicular implants.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2007;264(1):21-5.
2005: Erling Myrseth; Per Møller; Paal-Henning Pedersen; Flemming S Vassbotn; Tore Wentzel-Larsen; Morten Lund-Johansen
Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery.
Neurosurgery 2005;56(5):927-35; discussion 927-35.
2002: Flemming S Vassbotn; Olav G Klausen; Ola Lind; Per Moller
Acute mastoiditis in a Norwegian population: a 20 year retrospective study.
International journal of pediatric otorhinolaryngology 2002;62(3):237-42.
2002: Frode Selheim; Holm Holmsen; Flemming S Vassbotn
Identification of functional VEGF receptors on human platelets.
FEBS letters 2002;512(1-3):107-10.
2000: Frode Selheim; A K Frøyset; I Strand; Flemming S Vassbotn; Holm Holmsen
Adrenaline potentiates PI 3-kinase in platelets stimulated with thrombin and SFRLLN: role of secreted ADP.
FEBS letters 2000;485(1):62-6.
2000: Frode Selheim; Miriam H Fukami; Holm Holmsen; Flemming S Vassbotn
Platelet-derived-growth-factor-induced signalling in human platelets: phosphoinositide-3-kinase-dependent inhibition of platelet activation.
The Biochemical journal 2000;350 Pt 2():469-75.
2000: Frode Selheim; Holm Holmsen; Flemming S Vassbotn
PI 3-kinase signalling in platelets: the significance of synergistic, autocrine stimulation.
Platelets 2000;11(2):69-82.
1999: Frode Selheim; R Idsøe; Miriam H Fukami; Holm Holmsen; Flemming S Vassbotn
Formation of PI 3-kinase products in platelets by thrombin, but not collagen, is dependent on synergistic autocrine stimulation, particularly through secreted ADP.
Biochemical and biophysical research communications 1999;263(3):780-5.
1999: Frode Selheim; Holm Holmsen; Flemming S Vassbotn
Platelet-derived growth factor inhibits platelet activation in heparinized whole blood.
Thrombosis research 1999;95(4):185-96.
1994: Flemming S Vassbotn; O K Havnen; Carl-Henrik Heldin; Holm Holmsen
Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor.
The Journal of biological chemistry 1994;269(19):13874-9.
1994: Flemming S Vassbotn; Arne Ostman; Nina Langeland; Holm Holmsen; Bengt Westermark; Carl-Henrik Heldin; Monica Nistér
Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line.
Journal of cellular physiology 1994;158(2):381-9.
1993: Flemming S Vassbotn; M Andersson; Bengt Westermark; Carl-Henrik Heldin; Arne Ostman
Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant.
Molecular and cellular biology 1993;13(7):4066-76.
1992: Flemming S Vassbotn; R Skar; Holm Holmsen; Johan R Lillehaug
Absence of PDGF-induced, PKC-independent c-fos expression in a chemically transformed C3H/10T1/2 cell clone.
Experimental cell research 1992;202(1):98-104.
1992: Flemming S Vassbotn; Arne Ostman; Agneta Siegbahn; Holm Holmsen; Carl-Henrik Heldin
Neomycin is a platelet-derived growth factor (PDGF) antagonist that allows discrimination of PDGF alpha- and beta-receptor signals in cells expressing both receptor types.
The Journal of biological chemistry 1992;267(22):15635-41.
1992: A Smits; Keiko Funa; Flemming S Vassbotn; M Beausang-Linder; F af Ekenstam; Carl-Henrik Heldin; Bengt Westermark; Monica Nistér
Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin.
The American journal of pathology 1992;140(3):639-48.
1990: Flemming S Vassbotn; Nina Langeland; I Hagen; Holm Holmsen
A monoclonal antibody against PDGF B-chain inhibits PDGF-induced DNA synthesis in C3H fibroblasts and prevents binding of PDGF to its receptor.
Biochimica et biophysica acta 1990;1054(2):246-9.
1990: Flemming S Vassbotn; Nina Langeland; Holm Holmsen
Neomycin inhibits PDGF-induced IP3 formation and DNA synthesis but not PDGF-stimulated uptake of inorganic phosphate in C3H/10T1/2 fibroblasts.
Biochimica et biophysica acta 1990;1054(2):207-12.